Xi Chen
Xi Chen is the Founder and CEO of RootPath. He has over ten years of experience leading R&D, business development, and corporate strategy in various positions. Prior to joining industry, he was a Jane Coffin Childs postdoctoral fellow at Wyss Institute for Biologically Inspired Engineering at Harvard University working on the application of DNA molecular programming in early cancer detection. He was also a CPRIT research fellow at the University of Texas at Austin, where he led theoretical and applied research on DNA biophysics, molecular programming, and synthetic biology. He received his Ph.D. in Biochemistry from the University of Texas at Austin and a B.S. in Biotechnology from Shanghai Jiao Tong University.
RootPath
Deconstructing Cellular Diversity: Single-Cell Sequencing for Drug Discovery and Synthetic Biology
-
This session will highlight how single-cell sequencing technologies are transforming our ability to identify novel therapeutic targets, optimize engineered cell lines, and accelerate the drug discovery pipeline. By dissecting cellular heterogeneity at unprecedented resolution, these approaches are revealing intricate gene-expression patterns and pathway dynamics that guide the design of synthetic biological systems with greater precision. From refining the selection of promising drug candidates to informing the rational engineering of cell-based models, the discussion will explore how single-cell insights are redefining the frontiers of synthetic biology and unlocking new opportunities for innovative drug discovery.
Conference Pass
2,495
USD
Keynotes & Firesides
Workshops & Breakouts
1:1 Partnering App
Meals & Receptions
Session Recordings
Until Friday April 18th
Full Rate:
$3,495
